- About this Journal ·
- Abstracting and Indexing ·
- Advance Access ·
- Aims and Scope ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Journal of Obesity
Volume 2011 (2011), Article ID 297315, 7 pages
An Evidence-Based Review of Fat Modifying Supplemental Weight Loss Products
1Department of Pharmacy Practice, Jefferson School of Pharmacy, Thomas Jefferson University, Philadelphia, PA 19107-5233, USA
2Department of Pharmacy Sciences, School of Pharmacy and Health Professions, Creighton University, 2500 California Plaza, Omaha, NE 68178, USA
3Department of Pharmacy Practice, School of Pharmacy and Health Professions, Creighton University, 2500 California Plaza, Omaha, NE 68178, USA
Received 17 May 2010; Accepted 9 June 2010
Academic Editor: Alfredo Halpern
Copyright © 2011 Amy M. Egras et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- K. M. Flegal, M. D. Carroll, C. L. Ogden, and L. R. Curtin, “Prevalence and trends in obesity among US adults, 1999–2008,” Journal of the American Medical Association, vol. 303, no. 3, pp. 235–241, 2010.
- E. A. Finkelstein, J. G. Trogdon, J. W. Cohen, and W. Dietz, “Annual medical spending attributable to obesity: payer-and service-specific estimates,” Health Affairs, vol. 28, no. 5, pp. w822–w831, 2009.
- National Institutes of Health, U.S. Department of Health and Human Services, Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults, NIH publication, Bethesda, Md, USA, 1998.
- H. M. Blanck, M. K. Serdula, C. Gillespie et al., “Use of nonprescription dietary supplements for weight loss is common among Americans,” Journal of the American Dietetic Association, vol. 107, no. 3, pp. 441–447, 2007.
- J. L. Pillitteri, S. Shiffman, J. M. Rohay, A. M. Harkins, S. L. Burton, and T. A. Wadden, “Use of dietary supplements for weight loss in the united states: results of a national survey,” Obesity, vol. 16, no. 4, pp. 790–796, 2008.
- D. Heber, “Herbal preparations for obesity: are they useful?” Primary Care: Clinics in Office Practice, vol. 30, no. 2, pp. 441–463, 2003.
- “Conjugated linoleic acid,” in Natural Medicines Comprehensive Database, Therapeutic Research Faculty, Stockton, Calif, USA, Updated (periodically).
- J.-M. Gaullier, J. Halse, K. Høye et al., “Conjugated linoleic acid supplementation for 1 y reduces body fat mass in healthy overweight humans,” American Journal of Clinical Nutrition, vol. 79, no. 6, pp. 1118–1125, 2004.
- H. Blankson, J. A. Stakkestad, H. Fagertun, E. Thom, J. Wadstein, and O. Gudmundsen, “Conjugated linoleic acid reduces body fat mass in overweight and obese humans,” Journal of Nutrition, vol. 130, no. 12, pp. 2943–2948, 2000.
- U. Risérus, L. Berglund, and B. Vessby, “Conjugated linoleic acid (CLA) reduced abdominal adipose tissue in obese middle-aged men with signs of the metabolic syndrome: a randomised controlled trial,” International Journal of Obesity, vol. 25, no. 8, pp. 1129–1135, 2001.
- A. Smedman and B. Vessby, “Conjugated linoleic acid supplementation in humans—metabolic effects,” Lipids, vol. 36, no. 8, pp. 773–781, 2001.
- J.-M. Gaullier, J. Halse, K. Høye et al., “Supplementation with conjugated linoleic acid for 24 months is well tolerated by and reduces body fat mass in healthy, overweight humans,” Journal of Nutrition, vol. 135, no. 4, pp. 778–784, 2005.
- S. B. Heymsfield, D. B. Allison, J. R. Vasselli, A. Pietrobelli, D. Greenfield, and C. Nunez, “Garcinia cambogia (hydroxycitric acid) as a potential antiobesity agent,” Journal of the American Medical Association, vol. 280, no. 18, pp. 1596–1600, 1998.
- R. D. Mattes and L. Bormann, “Effects of (-)-hydroxycitric acid on appetitive variables,” Physiology and Behavior, vol. 71, no. 1-2, pp. 87–94, 2000.
- M. H. Pittler, N. C. Abbot, E. F. Harkness, and E. Ernst, “Randomized, double-blind trial of chitosan for body weight reduction,” European Journal of Clinical Nutrition, vol. 53, no. 5, pp. 379–381, 1999.
- R. N. Schiller, E. Barrager, A. G. Schauss, and E. J. Nichols, “A randomized, double-blind, placebo-controlled study examining the effects of a rapidly soluble chitosan dietary supplement on weight loss and body composition in overweight and mildly obese individuals,” Journal of the American Nutraceutical Association, vol. 4, pp. 42–49, 2001.
- C. Ni Mhurchu, S. D. Poppitt, A.-T. McGill et al., “The effect of the dietary supplement, chitosan, on body weight: a randomised controlled trial in 250 overweight and obese adults,” International Journal of Obesity, vol. 28, no. 9, pp. 1149–1156, 2004.
- G. R. Kaats, J. E. Michalek, and H. G. Preuss, “Evaluating efficacy of a chitosan product using a double-blinded, placebo-controlled protocol,” Journal of the American College of Nutrition, vol. 25, no. 5, pp. 389–394, 2006.
- R. T. Stanko, D. L. Tietze, and J. E. Arch, “Body composition, energy utilization, and nitrogen metabolism with a 4.25- MJ/d low-energy diet supplemented with pyruvate,” American Journal of Clinical Nutrition, vol. 56, no. 4, pp. 630–635, 1992.
- D. Kalman, C. M. Colker, R. Stark, A. Minsch, I. Wilets, and J. Antonio, “Effect of pyruvate supplementation on body composition and mood,” Current Therapeutic Research, vol. 59, no. 11, pp. 793–802, 1998.
- D. Kalman, C. M. Colker, I. Wilets, J. B. Roufs, and J. Antonio, “The effects of pyruvate supplementation on body composition in overweight individuals,” Nutrition, vol. 15, no. 5, pp. 337–340, 1999.
- J. L. Ngondi, J. E. Oben, and S. R. Minka, “The effect of Irvingia gabonensis seeds on body weight and blood lipids of obese subjects in Cameroon,” Lipids in Health and Disease, vol. 4, article 12, 2005.
- J. L. Ngondi, B. C. Etoundi, C. B. Nyangono, C. M. F. Mbofung, and J. E. Oben, “IGOB131, a novel seed extract of the West African plant Irvingia gabonensis, significantly reduces body weight and improves metabolic parameters in overweight humans in a randomized double-blind placebo controlled investigation,” Lipids in Health and Disease, vol. 8, article 7, 2009.
- D. C. Nieman, E. J. Cayea, M. D. Austin, D. A. Henson, S. R. McAnulty, and F. Jin, “Chia seed does not promote weight loss or alter disease risk factors in overweight adults,” Nutrition Research, vol. 29, no. 6, pp. 414–418, 2009.
- “Garcinia cambogia,” in Natural Medicines Comprehensive Database, Therapeutic Research Faculty, Stockton, Calif, USA, Updated (periodically).
- L. Dara, J. Hewett, and J. K. Lim, “Hydroxycut hepatotoxicity: a case series and review of liver toxicity from herbal weight loss supplements,” World Journal of Gastroenterology, vol. 14, no. 45, pp. 6999–7004, 2008.
- “Chitosan,” in Natural Medicines Comprehensive Database, Therapeutic Research Faculty, Stockton, Calif, USA, Updated (periodically).
- A. B. Jull, C. Ni Mhurchu, D. A. Bennett, C. A. E. Dunshea-Mooij, and A. Rodgers, “Chitosan for overweight or obesity,” Cochrane Database of Systematic Reviews, no. 3, Article ID CD003892, 2008.
- “Pyruvate,” in Natural Medicines Comprehensive Database, Therapeutic Research Faculty, Stockton, Calif, USA, Updated (periodically).
- “Irvingia gabonensis,” in Natural Medicines Comprehensive Database, Therapeutic Research Faculty, Stockton, Calif, USA, Updated (periodically).
- “Salvia hispanica,” in Natural Medicines Comprehensive Database, Therapeutic Research Faculty, Stockton, Calif, USA, Updated (periodically).